Search Results
Results for: SECURA BIO, INC (Save this search)
Number of Results: 2
SECURA BIO ACQUIRES RIGHTS TO FARYDAK FROM NOVARTIS
Nevada, US-based commercial stage biopharmaceutical company Secura Bio, Inc. has acquired the global rights to Farydak (panobinostat) from Novartis for treating multiple myeloma, t...

Secura Bio Acquires Rights to Farydak from Novartis
14 March 2019 - Nevada, US-based commercial stage biopharmaceutical company Secura Bio, Inc. has acquired the global rights to Farydak (panobinostat) from Novartis for treating mul...






















You can compare news articles by clicking on the tick buttons